Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | BOC | Class A common stock, par value $0.001 per share | Other | -20K | -1.86% | 1.06M | Dec 22, 2022 | Direct | F1, F2, F3, F4 | ||
transaction | BOC | Class A common stock, par value $0.001 per share | Other | -129K | -12.04% | 939K | Jun 2, 2023 | Direct | F2, F3, F4, F5 | ||
transaction | BOC | Class A common stock, par value $0.001 per share | Sale | -$229K | -11.6K | -1.24% | $19.74 | 928K | Jun 5, 2023 | Direct | F2, F3, F4, F6, F7 |
Id | Content |
---|---|
F1 | On December 22, 2022, Boulderado Partners, LLC ("BP") redeemed interests of BP held by two foundations that are limited partners of BP in a specific A-3 zero fee series (collectively, the "Foundations"), in consideration for the distribution to each such Foundation of 10,000 shares of Class A common stock of the Issuer. Mr. Rozek is the President of each of the Foundations and may exercise voting and dispositive power over the Class A common stock held by the Foundations, but Mr. Rozek disclaims beneficial ownership over such shares and this report shall not be deemed an admission of beneficial ownership of these securities for Section 16 or for any other purposes. |
F2 | Boulderado Capital, LLC ("BC"), Boulderado Group, LLC ("BG") and Mr. Rozek disclaim beneficial ownership except to the extent of their respective pecuniary interests therein, and this report shall not be deemed an admission of beneficial ownership of these securities for Section 16 or for any other purposes. |
F3 | Mr. Rozek serves as a director of the Issuer and is the Co-Chief Executive Officer and Co-President of the Issuer. |
F4 | The reported shares are directly owned by BP, other than the shares distributed to the Foundations as described in footnote (1), to the Foundation and the Trusts as described in footnote (5) and as sold by the Medical Trust as described in footnote (6). BC is the managing member of BP. BG is the investment manager of BP. Mr. Rozek is the managing member of BP, BC and BG. BP, BC, BG and Mr. Rozek disclaim beneficial ownership except to the extent of their respective pecuniary interests therein, and this report shall not be deemed an admission of beneficial ownership of these securities for Section 16 or for any other purposes. |
F5 | On June 2, 2023, BP redeemed interests of BP held by one of the Foundations and three trusts that were limited partners of BP (collectively, the "Trusts"), including the Doris Buffett Medical Support Trust (the "Medical Trust"), in consideration of the distribution to one of the Foundations of 43,000 shares, and to the Trusts of 11,600 shares, 11,800 shares and 62,150 shares, respectively, of Class A common stock of the Issuer. Mr. Rozek is the President of each of the Foundations and is a trustee of each of the Trusts, and may exercise voting and dispositive power over the Class A common stock held by the Foundations and the Trusts. BP, BC, BG and Mr. Rozek disclaim beneficial ownership over such shares held by the Foundations and each of the Trusts, except that with regard to the Medical Trust, Mr. Rozek disclaims beneficial ownership except to the extent of his pecuniary interest therein. |
F6 | The shares reported in Column 4 were sold by the Medical Trust. |
F7 | The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $19.70 to $19.87, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (7) to this Form 4. |